213 related articles for article (PubMed ID: 8940748)
1. The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy.
Bristow RG; Benchimol S; Hill RP
Radiother Oncol; 1996 Sep; 40(3):197-223. PubMed ID: 8940748
[TBL] [Abstract][Full Text] [Related]
2. WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells.
Cuddihy AR; Jalali F; Coackley C; Bristow RG
Mol Cancer Ther; 2008 Apr; 7(4):980-92. PubMed ID: 18413811
[TBL] [Abstract][Full Text] [Related]
3. Radioresistant MTp53-expressing rat embryo cell transformants exhibit increased DNA-dsb rejoining during exposure to ionizing radiation.
Bristow RG; Hu Q; Jang A; Chung S; Peacock J; Benchimol S; Hill R
Oncogene; 1998 Apr; 16(14):1789-802. PubMed ID: 9583677
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
5. P53-mediated radioresistance does not correlate with metastatic potential in tumorigenic rat embryo cell lines following oncogene transfection.
Bristow RG; Brail L; Jang A; Peacock J; Chung S; Benchimol S; Hill RP
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):341-55. PubMed ID: 8567335
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53, p21/WAF/CIP, Bcl-2, Bax, Bcl-x, and Bak in radiation-induced apoptosis in testicular germ cell tumor lines.
Burger H; Nooter K; Boersma AW; Kortland CJ; van den Berg AP; Stoter G
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):415-24. PubMed ID: 9607360
[TBL] [Abstract][Full Text] [Related]
7. Repair of DNA double-strand breaks and radiosensitivity to killing in an isogenic group of p53 mutant cell lines.
DiBiase SJ; Guan J; Curran WJ; Iliakis G
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):743-51. PubMed ID: 10524431
[TBL] [Abstract][Full Text] [Related]
8. Resistance to DNA-damaging agents is discordant from experimental metastatic capacity in MEF ras-transformants-expressing gain of function MTp53.
Bristow RG; Peacock J; Jang A; Kim J; Hill RP; Benchimol S
Oncogene; 2003 May; 22(19):2960-6. PubMed ID: 12771947
[TBL] [Abstract][Full Text] [Related]
9. A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours.
Habib NA; Hodgson HJ; Lemoine N; Pignatelli M
Hum Gene Ther; 1999 Aug; 10(12):2019-34. PubMed ID: 10466636
[TBL] [Abstract][Full Text] [Related]
10. Combined RAF1 protein expression and p53 mutational status provides a strong predictor of cellular radiosensitivity.
Warenius HM; Jones M; Gorman T; McLeish R; Seabra L; Barraclough R; Rudland P
Br J Cancer; 2000 Oct; 83(8):1084-95. PubMed ID: 10993658
[TBL] [Abstract][Full Text] [Related]
11. The p53 protein family and radiation sensitivity: Yes or no?
Cuddihy AR; Bristow RG
Cancer Metastasis Rev; 2004; 23(3-4):237-57. PubMed ID: 15197326
[TBL] [Abstract][Full Text] [Related]
12. The effect of p21 antisense oligodeoxynucleotides on the radiosensitivity of nasopharyngeal carcinoma cells with normal p53 function.
Liu XF; Xia YF; Li MZ; Wang HM; He YX; Zheng ML; Yang HL; Huang WL
Cell Biol Int; 2006 Mar; 30(3):283-7. PubMed ID: 16448826
[TBL] [Abstract][Full Text] [Related]
13. Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells.
Böhnke A; Westphal F; Schmidt A; El-Awady RA; Dahm-Daphi J
Int J Radiat Biol; 2004 Jan; 80(1):53-63. PubMed ID: 14761850
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity.
McIlwrath AJ; Vasey PA; Ross GM; Brown R
Cancer Res; 1994 Jul; 54(14):3718-22. PubMed ID: 8033090
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic damage and the radiation-induced G1-phase checkpoint.
Gupta N; Vij R; Haas-Kogan DA; Israel MA; Deen DF; Morgan WF
Radiat Res; 1996 Mar; 145(3):289-98. PubMed ID: 8927696
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation.
DeWeese TL; Walsh JC; Dillehay LE; Kessis TD; Hedrick L; Cho KR; Nelson WG
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):145-54. PubMed ID: 9054890
[TBL] [Abstract][Full Text] [Related]
17. p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines.
Servomaa K; Kiuru A; Grénman R; Pekkola-Heino K; Pulkkinen JO; Rytömaa T
Cell Prolif; 1996 May; 29(5):219-30. PubMed ID: 8782485
[TBL] [Abstract][Full Text] [Related]
18. [Effect of DNA-PKcs antisense oligodeoxynucleotides on radiosensitivity of nasopharyngeal carcinoma cell lines with different p53 function statuses].
Jiang CB; Liu XF; He YX
Ai Zheng; 2008 Feb; 27(2):139-43. PubMed ID: 18279609
[TBL] [Abstract][Full Text] [Related]
19. Role of cell cycle in mediating sensitivity to radiotherapy.
Pawlik TM; Keyomarsi K
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):928-42. PubMed ID: 15234026
[TBL] [Abstract][Full Text] [Related]
20. p53 mutations increase resistance to ionizing radiation.
Lee JM; Bernstein A
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5742-6. PubMed ID: 8516323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
